Ameriprise Financial Inc Chimerix Inc Transaction History

Ameriprise Financial Inc

$364 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.9 - $1.06 $24,030 - $28,302	26,700 New	26,700 $25,000
Q2 2023 Aug 14, 2023	BUY	$1.1 - $1.54 $3,219 - $4,507	2,927 Added 4.29%	71,146 $86,000
Q1 2023 May 15, 2023	BUY	$1.19 - $2.09 $2,313 - $4,062	1,944 Added 2.93%	68,219 $85,000
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.35 $27,244 - $38,337	16,314 Added 32.65%	66,275 $123,000
Q3 2022 Nov 14, 2022	BUY	$1.81 - $2.76 $4,253 - $6,485	2,350 Added 4.94%	49,961 $96,000
Q2 2022 Aug 15, 2022	BUY	$1.34 - $5.34 $31,102 - $123,946	23,211 Added 95.13%	47,611 $99,000
Q1 2022 May 16, 2022	SELL	$4.58 - $6.8 $1,465 - $2,176	-320 Reduced 1.29%	24,400 $112,000
Q4 2021 Feb 14, 2022	SELL	$5.23 - $7.18 $40,846 - $56,075	-7,810 Reduced 24.01%	24,720 $159,000
Q3 2021 Nov 15, 2021	BUY	$5.94 - $8.75 $3,148 - $4,637	530 Added 1.66%	32,530 $201,000
Q2 2021 Aug 16, 2021	BUY	$7.54 - $9.79 $241,280 - $313,280	32,000 New	32,000 $256,000
Q1 2021 May 17, 2021	SELL	$4.76 - $11.25 $326,883 - $772,571	-68,673 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$2.43 - $5.42 $100,378 - $223,889	-41,308 Reduced 37.56%	68,673 $331,000
Q3 2020 Nov 16, 2020	BUY	$2.3 - $3.72 $15,596 - $25,225	6,781 Added 6.57%	109,981 $274,000
Q2 2020 Aug 14, 2020	BUY	$1.33 - $3.63 $137,256 - $374,616	103,200 New	103,200 $320,000
Q1 2020 May 15, 2020	SELL	$1.27 - $2.33 $101,907 - $186,963	-80,242 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.3 - $2.72 $13,322 - $27,874	10,248 Added 14.64%	80,242 $163,000
Q3 2019 Nov 14, 2019	BUY	$1.93 - $4.21 $135,088 - $294,674	69,994 New	69,994 $165,000
Q1 2019 May 15, 2019	SELL	$1.79 - $3.12 $106,449 - $185,543	-59,469 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$2.24 - $3.9 $10,080 - $17,550	-4,500 Reduced 7.03%	59,469 $153,000
Q3 2018 Nov 14, 2018	SELL	$3.58 - $4.9 $23,556 - $32,242	-6,580 Reduced 9.33%	63,969 $249,000
Q2 2018 Aug 14, 2018	SELL	$4.43 - $5.14 $14,707 - $17,064	-3,320 Reduced 4.49%	70,549 $336,000
Q1 2018 May 15, 2018	BUY	$4.65 - $5.9 $134,231 - $170,315	28,867 Added 64.15%	73,869 $384,000
Q4 2017 Feb 12, 2018	BUY	$4.32 - $5.52 $61,905 - $79,101	14,330 Added 46.72%	45,002 $208,000
Q3 2017 Nov 07, 2017	BUY	$4.35 - $5.25 $133,423 - $161,028	30,672	30,672 $161,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

Ra Capital Management, L.P. Boston, MA

8.8M
Shares

$8.54 Million
0.12% of portfolio
Monaco Asset Management Sam

4.38M
Shares

$4.25 Million
0.63% of portfolio
Vanguard Group Inc Valley Forge, PA

4.35M
Shares

$4.22 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

2.22M
Shares

$2.16 Million
0.03% of portfolio
Acadian Asset Management LLC Boston, MA

2.17M
Shares

$2.11 Million
0.01% of portfolio

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account